Stephen J. Pace - Jun 7, 2023 Form 4 Insider Report for Dynatrace, Inc. (DT)

Signature
/s/ Anne-Celine Woelk, by power of attorney
Stock symbol
DT
Transactions as of
Jun 7, 2023
Transactions value $
-$2,302,568
Form type
4
Date filed
6/9/2023, 06:05 PM
Previous filing
Jun 2, 2023
Next filing
Jun 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DT Common Stock Sale -$1.36M -26.2K -13.67% $51.75 166K Jun 7, 2023 Direct F1, F2
transaction DT Common Stock Options Exercise $544K +16.5K +9.95% $33.03 182K Jun 9, 2023 Direct
transaction DT Common Stock Sale -$1.49M -29.2K -16.03% $51.07 153K Jun 9, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DT Stock Option (Right to Buy) Options Exercise $0 +16.5K +40.29% $0.00 57.4K Jun 9, 2023 Common Stock 16.5K $33.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to the Issuer's mandatory sale-to-cover policy applicable to tax withholding obligations resulting from the vesting of RSUs and PSUs.
F2 The number of securities reported reflects the acquisition on June 5, 2023 of 694 shares of Dynatrace, Inc. common stock pursuant to the Dynatrace Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP offering period of December 5, 2022 through June 5, 2023.
F3 The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4 Stock options granted on May 15, 2020, 25% of which became exercisable and vested on May 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.